Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,756
Closed -$338K 2088
2025
Q4
$338K Buy
+6,756
New +$325K ﹤0.01% 1616
2025
Q3
Sell
-99,220
Closed -$5.45M 1676
2025
Q2
$5.45M Sell
99,220
-1,195
-1% -$54.9K ﹤0.01% 909
2025
Q1
$4.03M Buy
100,415
+100,287
+78,349% +$5.18M ﹤0.01% 1007
2024
Q4
$6.71K Sell
128
-49,621
-100% -$2.57M ﹤0.01% 1926
2024
Q3
$2.14M Buy
+49,749
New +$2.18M ﹤0.01% 1142
2023
Q2
Sell
-693
Closed -$21.4K 2127
2023
Q1
$21.4K Hold
693
﹤0.01% 1957
2022
Q4
$26K Hold
693
﹤0.01% 1774
2022
Q3
$26K Hold
693
﹤0.01% 1736
2022
Q2
$25K Buy
+693
New +$28.7K ﹤0.01% 1587

Other funds holding SNV

Amundi's SNV Position: Q1 2026 in Review

Amundi sold out of Synovus (SNV) in Q1 2026, closing a stake of 6,756 shares — an estimated $338K sold.

Amundi first reported a position in SNV in Q2 2022 and held it in 9 quarters. The position peaked at $5.45M in Q2 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Amundi reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Amundi sold 6,756 Synovus shares in Q1 2026, an estimated $338K.
  • Amundi first reported a position in Synovus in Q2 2022 and held it in 9 quarters.
  • Amundi's Synovus position peaked at $5.45M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.